Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Teva Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Uncle Mikey who wrote (135)	12/16/1997 2:29:00 PM
From: Ron Kline	Read Replies (1) \| Respond to of 340

Controlled release drugs due just that, they control the release of the drug so that you have simplified dosage schedules. Some drugs have a long half life (meaning the drug works for longer periods of time), and so you don't need to take a drug very often for it to work for long times. But many like procardia have a much shorter duration of action. These are the drugs where big pharms have developed controlled release formulations. What this does is allow you to take one pill a day instead of 3. So when for example procardia became generic Pfizer developed a controlled release version to add life to the drug. If you wanted the generic procardia you would need to take the 3 tablets a day, whereas the new XL version was a one a day. Then what they do is show all these studies as to why you should have the patient on the one a day formulation. They show things like compiance goes up, delivery is more constant, and therefore there are less visits to doctors and saves money to the healthcare organizations. It's worked great to keep out generics. So now Teva is going to play the same game, and so the big pharms are not going to have that kind of advantage on some drugs. It's difficult to develop good CR systems for many drugs so the fact they have rights to this new technology is really great and worth every penny. Teva has smart management and they are going in the right direction IMO.